Shares of US vaccine-maker Moderna soared 60 per cent in pre-market trading after the company reported successful results for a melanoma cancer vaccine that is being developed with Merck.
美国疫苗制造商莫德纳(Moderna)股价在盘前交易中飙升60%，此前该公司报告称，与默沙东(MSD)联合开发的黑色素瘤疫苗取得了成功结果。
您已阅读17%（257字），剩余83%（1218字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。